Beta-galactosidase deficiency in the hurler syndrome. 1969

M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008059 Mucopolysaccharidosis I Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing. Hurler's Syndrome,Hurler-Scheie Syndrome,Lipochondrodystrophy,Mucopolysaccharidosis V,Pfaundler-Hurler Syndrome,Scheie's Syndrome,Gargoylism,Gargoylism, Hurler Syndrome,Hurler Disease,Hurler Syndrome,Hurler's Disease,Mucopolysaccharidosis 1,Mucopolysaccharidosis 5,Mucopolysaccharidosis I-S,Mucopolysaccharidosis Type I,Mucopolysaccharidosis Type Ih,Mucopolysaccharidosis Type Ih S,Mucopolysaccharidosis Type Is,Scheie Syndrome,alpha-L-Iduronidase Deficiency,Disease, Hurler's,Gargoylisms,Hurler Scheie Syndrome,Hurler Syndrome Gargoylism,Lipochondrodystrophies,Mucopolysaccharidosis I S,Mucopolysaccharidosis Is,Mucopolysaccharidosis Type Ihs,Syndrome, Hurler's,Syndrome, Scheie's,Type Ih, Mucopolysaccharidosis,Type Ihs, Mucopolysaccharidosis,alpha L Iduronidase Deficiency,alpha-L-Iduronidase Deficiencies
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005696 Galactosidases A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-. Galactosidase
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids

Related Publications

M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
January 2000, Ryoikibetsu shokogun shirizu,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
April 1969, The New England journal of medicine,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
January 1998, Ryoikibetsu shokogun shirizu,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
July 1978, Clinical genetics,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
August 1969, Science (New York, N.Y.),
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
May 1968, Science (New York, N.Y.),
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
April 1987, Clinica chimica acta; international journal of clinical chemistry,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
July 1981, Journal of biochemistry,
M MacBrinn, and S Okada, and M Woollacott, and V Patel, and M W Ho, and A L Tappel, and J S O'Brien
November 1974, Lancet (London, England),
Copied contents to your clipboard!